India: "SOREX Deceptively Similar To COREX"

Last Updated: 2 June 2011
Article by Sonam Lhamu Bhutia and Vasundhara Kamath S

In the case of Pfizer Products, Inc & Anr v. Vijay Shah & Ors, the Plaintiffs, being the subsidiaries of the multinational pharmaceutical company, Pfizer Inc., had been engaged in the manufacture of an array of products including vitamin, supplements, antibiotics etc. They had been producing the popular drug "COREX" worldwide for the treatment of cough and for allergic or infective conditions of the respiratory passage. In India the mark was registered in 1963 in the name of the First Plaintiff, Pfizer Product Inc. and was thereafter being sold by them.

In 2007, the Plaintiffs came to know that Stallion Laboratories Pvt. Ltd. (hereinafter referred to as Defendant No. 2) was manufacturing and marketing a cough syrup under the mark "SOREX", which was similar to their mark and had an identical label, packaging and get-up. In the wake of such finding, they sought for an injunction restraining the Defendants and their officers, etc, from manufacturing, marketing or advertising SOREX or any other mark that was identical or deceptively similar to the Plaintiff's registered Trademark. It was their contention that the Defendants were trying to ride upon their goodwill and reputation. According to them there was also likelihood that such similarity would create an impression in the minds of the customers as to their association with the Defendant's product and with regard to likeness of the quality of the two products.

They also prayed for an injunction restraining the Defendants from reproducing and/or using the Plaintiff's trade-dress comprised of get-up, layout, colour scheme and the arrangement of the features in the packaging for its product. Besides injunction, they also prayed before the Court for rendition of accounts and damages from the Defendant.

Vijay Shah (hereinafter referred to as Defendant No. 1) was the Managing Director of Defendant No. 2 Company. Defendant No. 3 was marketing the product. While Defendants No. 1 and 2 did not contest the suit, the third Defendant filed its Written Statement. They contended that there were vast differences in their product and that of the Plaintiff's with respect to several factors such as contents on the label, size of the bottle, colour of the liquid etc. It was also stated that the Defendant's product was a narcotic drug for which a prescription by a doctor was a must. Furthermore, the Court was also informed that the production and marketing of SOREX had been terminated. After the filing of the Written Statement, the third Defendant was also proceeded ex parte.

The Plaintiffs, thereafter, filed their Affidavit, in which they alleged that the product of the Defendant not only carried visual, structural and phonetic similarity, but also had an identical get-up, layout and arrangement of words and colour scheme. In order to substantiate the same, photographs of the two products were also produced before the Court.

In addition, the Plaintiffs relied on Section 28 of the Trademarks Act as per which the registered proprietor of the mark has the exclusive right to use the same in relation to the goods and services in respect of which it was registered. It also allowed the registered proprietor to obtain relief in respect of the infringement of the Trademark in the manner provided in the Act. The Plaintiff clearly elucidated the circumstances that would lead to infringement and passing off and also identified the differences between the two.

It was observed by the Court that in case of passing off, the Defendant would be absolved of its liability if it were able to establish that on account of the packaging, get-up etc, an ordinary buyer could distinguish between its goods from those of the Plaintiff. Such was not the case with regard to the Defendant's goods since the differences were rather trivial.

The Court stressed on the need for honesty in adopting of a name for a product so that the goodwill and reputation of another would not be usurped. Care was to be taken to avoid fraudulent or deceptive copying of the trademark of another, since the same would amount to a false misrepresentation to the public. The need for the same was highlighted from the viewpoint of the customer and the manufacturer.

In response to the claim by the Defendants that their product was a prescription drug, the Court pointed out that in India cough syrups were often available over the counter without prescription and hence, small townsfolk possessing average intelligence would not be able to distinguish the features between the two products.

The observation of the Supreme Court in Cadila Health Care Ltd. v. Cadila Pharmaceuticals Ltd., 2001 PTC 541 (SC) was considered, wherein, the need for vigilance was underlined in cases of passing off with regard to products meant for the same ailments but containing different compositions. The need was felt more so in India since purchasers of such goods often had no knowledge of the English language.

On the basis of the abovementioned reasons, the Court found it expedient to grant injunction against the Defendants.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions